Overview

MPA PK Monitoring Strategy With MMF/FK Based Immunosuppression

Status:
Completed
Trial end date:
2006-11-01
Target enrollment:
Participant gender:
Summary
Individuals absorb Cellcept (MMF/Mycophenolate Mofetil) at different rates and it is difficult to determine an individuals level of Mycophenolate Mofetil (MMF, trade name Cellcept)from a single measurement. We will enroll 20 subjects. Plasma samples to be collected pre-MMF dose (trough level) and at 30 and 120 min after the morning dose of MMF.This will be done weekly for the first month and then monthly for the next 6 mths. We hope to use a calculation of the subjects total MMF level during the first month to set a trough target level to use during the next 6 months.
Phase:
Early Phase 1
Details
Lead Sponsor:
University of Florida
Collaborator:
Hoffmann-La Roche
Treatments:
Mycophenolate mofetil
Mycophenolic Acid